← Open Payments lookup

JILL SLONAKER: Open Payments

NPI 1053918409 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$757 in 47 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $372 · 2025 $757

Food & beverage: $757
CompanyPaymentsAmount
ABBVIE INC.15$166
Otsuka America Pharmaceutical, Inc.5$92
Novo Nordisk Inc5$86
Lilly USA, LLC4$71
AstraZeneca Pharmaceuticals LP4$64
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$49
Vanda Pharmaceuticals Inc.1$38
Boehringer Ingelheim Pharmaceuticals, Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$36
Axsome Therapeutics, Inc.2$29

Products named: VRAYLAR, REXULTI, JARDIANCE, MOUNJARO, CAPLYTA, Ozempic, FANAPT, Wegovy.

Industry payments across IN — which companies pay providers there.